Regulatory considerations when choosing stem cell media
This webinar from Sartorius (Göttingen, Germany) examines the key factors researchers must consider when transitioning from academia to industry or scaling up their operations.
Oren Ben-Yosef, Product Manager for Stem Cells, Advanced Therapies at Sartorius, will guide you through the essential criteria for choosing the correct stem cell media and supplier, emphasizing the importance of understanding Manufacturers’ Quality Systems.
What will you learn
- Regulatory terminology and how it applies in the stem cell field
- Insights into Manufacturers’ Quality Systems
- What the NutriStem media family offers to researchers and the industry
- Information about Biological Industries and Sartorius’ collaborations worldwide
Speaker
Oren Ben-Yosef
Product Manager for Stem Cells, Advanced Therapies
Sartorius (Beit HaEmek, Israel)
Oren has a BSc in Biotechnology Engineering and a PhD in Medical Sciences from the Technion Israel Institute of Technology (Haifa, Israel), where his research focused on culturing methods and differentiation of embryonic stem cells and induced pluripotent stem cells. Oren joined Biological Industries (Beit Haemek, Israel), now part of Sartorius, in 2016, and he has been a Product Manager for Stem Cells since 2019.
This resource is part of the RegMedNet Spotlight on cell and gene therapy regulation. Click here to view the full feature and discover expert insights on this >>>
